Liver transplantation arrests and reverses muscle wasting

Clinical Transplantation

Volumn 29, Issue 3, 2015, Pages 216-221

  Bergerson, Joseph T ^a   Lee, Jun Goo ^a   Furlan, Alessandro ^a   Sourianarayanane, Achuthan ^b   Fetzer, David T ^a   Tevar, Amit D ^c   Landsittel, Douglas P ^c,d   Dimartini, Andrea F ^a,c   Dunn, Michael A ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cirrhosis; Liver; Muscle; Sarcopenia; Transplant

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALLOGRAFT; ARTICLE; ASSESSMENT OF HUMANS; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; ISCHEMIA; KIDNEY FAILURE; LIVER TRANSPLANTATION; MALE; MUSCLE MASS; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; POST TRANSPLANT MUSCLE WASTING; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SARCOPENIA; SEPSIS; SKELETAL MUSCLE INDEX; EPIDEMIOLOGY; LIVER CIRRHOSIS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; LINEAR MODELS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; TREATMENT OUTCOME;

EID: 84925271555     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12506     Document Type: Article

References (22)

1. Englesbe MJ, Patel SP, He K et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010: 211: 271.
2. Cruz RJ Jr, Dew MA, Myaskovsky L et al. Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation 2013: 95: 617.
3. Dimartini A, Cruz RJ Jr, Dew MA et al. Muscle mass predicts outcomes following liver transplantation. Liver Transpl 2013: 19: 1172.
4. Montano-Loza AJ, Meza-Junco J, Baracos VE et al. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transpl 2014: 20: 640.
5. Montano-Loza AJ, Meza-Junco J, Prado CM et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012: 10: 166.
6. Tandon P, Ney M, Irwin I et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 2012: 18: 1209.
7. Durand F, Buyse S, Francoz C et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol 2014: 60: 1151.
8. Dasarathy S. Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation. Dig Dis Sci 2013: 58: 3103.
9. Tsien C, Garber A, Narayanan A et al. Post- liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol 2014: 29: 1250.
10. Prado CMM, Leiffers JR, McCargar LJ et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008: 9: 629.
11. MITK version 1.1. Division of Medical and Biological Informatics, German Cancer Research Institute. http://www.dkfz.de/en/mbi/index.html (accessed 31 March 2013).
12. Irving BA, Weltman JY, Brock DW, Davis CK, Gaesser GA, Weltman A. NIH ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue. Obesity (Silver Spring) 2007: 15: 370.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986: 1: 307.
14. Bonekamp S, Ghosh P, Crawford S et al. Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging. Int J Obes (Lond) 2008: 32: 100.
15. Rosner B. Fundamentals of Biostatistics, 7th edn. Boston, MA: Brooks/Cole CENGAGE Learning, 2011.
16. Lucey MR, Terrault N, Ojo L et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013: 19: 3.
17. Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle 2012: 3: 225.
18. Kachaamy T, Bajaj JS, Heuman DM. Muscle and mortality in cirrhosis. Clin Gastroenterol Hepatol 2012: 10: 100.
19. Qiu J, Thapaliya S, Runkana A et al. Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-kappaB-mediated mechanism. Proc Natl Acad Sci U S A 2013: 110: 18162.
20. Waters DL, Baumgartner RN, Garry PJ, Vellas B. Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 2010: 5: 259.
21. Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl 2012: 18: 146.
22. Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant 2014: 14: 1870.